Scandinavian Chemotech Ab Class BOMXSTO: CMOTEC_B

CMOTEC_B: 2024 saw record sales, improved results, and strong Animal Care growth, supporting future expansion

· Issued by Scandinavian Chemotech Ab Class B

Record revenue in 2024 driven by Animal Care, improved operating results, and strategic expansion in key markets. Loan restructuring and new orders support a positive outlook for 2025.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.